Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumors With an Alteration of the PIK3CA Gene × Fulvestrant × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Breast 1

Conditions

Advanced Solid Tumors 2 Solid Tumor, Adult 1 Solid Tumor 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced/Metastatic Solid Tumors 1 Advanced Solid Tumors With an Alteration of the PIK3CA Gene 1 Advanced Solid Tumor 1

Interventions

Fulvestrant 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01219699 2020-09-22

A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene

Novartis

Phase 1 Completed

BreastOther solid neoplasm

Advanced Solid Tumors With an Alteration of the PIK3CA Gene

Data powered by HemOnc (CC BY 4.0) Colophon ⚡